Assessment of vascular function in systemic sclerosis: Indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production

Arthritis and Rheumatism

Volumn 46, Issue 5, 2002, Pages 1324-1332

  Andersen, Grethe Neumann ^a   Mincheva Nilsson, Lucia ^a   Kazzam, Elsadig ^c   Nyberg, Gunnar ^b   Klintland, Natalia ^b   Petersson, Ann Sofi ^b   Rantapää Dahlqvist, Solbritt ^a   Waldenström, Anders ^a   Caidahl, Kenneth ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Malar Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TONOMETRY; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; BRACHIAL ARTERY; CYCLIC GMP; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; RADIAL ARTERY; REGIONAL BLOOD FLOW; SCLERODERMA, SYSTEMIC; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036090180     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10191     Document Type: Article

References (39)

1. Systemic sclerosis: A vascular perspective
2. Cold-induced reversible myocardial ischaemia in systemic sclerosis
3. Short-term effect of-cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon
4. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma
5. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma
6. Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis
7. Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenomenon and systemic sclerosis
8. Microvascular involvement in systemic sclerosis: Laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis
9. 2-adrenergic constriction of isolated arterioles in diffuse scleroderma
10. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis
11. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin
12. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1
13. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: Enhanced production and profibrotic action
14. Endothelin may be pathogenic in systemic sclerosis of the heart
15. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity
16. Serial circulating adhesion molecule levels reflect disease activity in systemic sclerosis
17. Pathologic observations in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls
18. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance
19. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
20. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
21. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
22. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis
23. Comparison between 3 diagnostic criteria for mixed connective tissue disease: Study of 593 patients
24. Raynaud's disease: A critical review of minimal requisites for diagnosis
25. Is it possible to reduce observer variability in skin score assessment of scleroderma?
26. Metabolism and excretion of nitric oxide in humans: An experimental and clinical study
27. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis
28. A methodological study of arterial wall function using ultrasound technique
29. Macroangiopathy of the upper extremities in progressive systemic sclerosis
30. Nitric oxide
31. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon
32. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilatation in women with Raynaud's phenomenon secondary to systemic sclerosis
33. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase
34. Possible mechanisms of nitrate tolerance
35. What causes tolerance to nitroglycerin? The 100 year old mystery continues
36. Adrenaline toxicity in mice: Sensitization of alpha 1 adrenoceptors by nitroglycerin
37. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance
38. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces
39. Down regulation of nitric oxide synthase gene in microvascular endothelial cells from lesional scleroderma: Assessment by quantitative RT-PCR and possible role for cytotoxic T-cells